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Abstract
A retrospective study of 2,146 feedlot cattle in 17 feedlot tests from 1988 to 1997 was conducted to determine
the impact of bovine respiratory disease (BRD) on veterinary treatment costs, average daily gain, carcass
traits, mortality, and net profit. Morbidity caused by BRD was 20.6%. The average cost to treat each case of
BRD was $12.39. Mortality rate of calves diagnosed and treated for BRD was 5.9% vs. .35% for those not
diagnosed with BRD. Average daily gain differed between treated and non-treated steers during the first 28
days on feed but did not differ from 28 days to harvest. Net profit was $57.48 lower for treated steers. Eighty-
two percent of this difference was due to a combination of mortality and treatment costs. Eighteen percent of
the net profit difference was due to improved performance and carcass value of the non-treated steers. Data
from 496 steers and heifers in nine feedlot tests were used to determine the effects of age, weaning, and use of
modified live virus or killed vaccines prior to the test to predict BRD. Younger calves, non-weaned calves, and
calves vaccinated with killed vaccines prior to the test had higher BRD morbidity than those that were older,
weaned, or vaccinated with modified live virus vaccines, respectively. Treatment regimes that precluded
relapse resulting in re-treatment prevented reduced performance and loss of carcass value. Using modified live
virus vaccines and weaning calves 30 days prior to shipment reduced the incidence of BRD.
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Summary
A retrospective study of 2,146 feedlot cattle in 17 feedlot
tests from 1988 to 1997 was conducted to determine the
impact of bovine respiratory disease (BRD) on
veterinary treatment costs, average daily gain, carcass
traits, mortality, and net profit. Morbidity caused by
BRD was 20.6%.  The average cost to treat each case of
BRD was $12.39. Mortality rate of calves diagnosed and
treated for BRD was 5.9% vs. .35% for those not
diagnosed with BRD. Average daily gain differed
between treated and non-treated steers during the first
28 days on feed but did not differ from 28 days to
harvest.  Net profit was $57.48 lower for treated steers.
Eighty-two percent of this difference was due to a
combination of mortality and treatment costs.   Eighteen
percent of the net profit difference was due to improved
performance and carcass value of the non-treated steers.
Data from 496 steers and heifers in nine feedlot tests
were used to determine the effects of age, weaning, and
use of modified live virus or killed vaccines prior to the
test to predict BRD.  Younger calves, non-weaned
calves, and calves vaccinated with killed vaccines prior
to the test had higher BRD morbidity than those that
were older, weaned, or vaccinated with modified live
virus vaccines, respectively.  Treatment regimes that
precluded relapse resulting in re-treatment prevented
reduced performance and loss of carcass value.   Using
modified live virus vaccines and weaning calves 30 days
prior to shipment reduced the incidence of BRD.
Introduction
Bovine respiratory disease (BRD) is the leading cause
of disease-induced economic loss in feedlots.  Financial
losses attributable to BRD include mortality, and
medication, veterinary, and labor costs for treatment.
Other losses are difficult to demonstrate.  These include
reduced feed efficiency (FE=pounds of feed required per
pound of gain), lower average daily gain (ADG), increased
days on feed, decreased weight at harvest, carcass trim and
possible condemnation, and reduced carcass quality grade.
It is difficult to demonstrate the effect of BRD on ADG and
FE because these production parameters are usually
measured by pen average rather than by differences between
individual animals (Jim et al., 1993).
Bovine respiratory disease is of multi-factorial origin.
Onset of disease depends on a complex interaction between
viruses, bacteria, the environment, and the host.   Disease
onset is thought to begin by reduced host resistance and
infection with one or more viral agents such as Infectious
Bovine Rhinotracheitis (IBR), Bovine Virus Diarrhea
(BVD), or Bovine Respiratory Syncytial Virus (BRSV).
Viral infection compromises resistance to bacterial infection
in a variety of ways, facilitating subsequent infection with
pathogenic bacteria.  Bacteria such as Pasteurella
haemolytica, Haemophilus somnus, and Pasteurella
multocida can become established in the lung, causing
pneumonia and fibrinous pleuritis.  However, pasteurella
pneumonia can occur without previous viral infection.
Cattle with pneumonia are usually febrile, inappetant,
depressed, and exhibit labored, shallow, and rapid breathing.
The ability of infectious agents to establish themselves
in the body is dependent upon many factors related to the
immuno-competance of the animal.  Temperature
fluctuations, humidity, rainfall, mud, nutritional status, age,
length of time weaned, number and virulence of organisms
shed by herd mates, vaccination and other factors interact
and affect the resistance of individual calves.  Exposure to a
variety of infectious agents upon entry into feedlots is often
extensive.  Defining the specific role of factors that
predispose cattle to respiratory disease is difficult.
Morbidity and mortality are usually not repeatable from one
group of cattle to the next because of inability to control
multiple variables at the micro level.  Few studies have
analyzed the effect of the many factors that could affect the
incidence, severity, and economic implications of BRD
because they must be conducted over several years.
Iowa State University Extension, with support from
several county cattlemen's organizations and
agri-businesses, has helped organize and conduct feedlot
tests for Iowa cow-calf producers from 1983 to the present.
These tests have been administered under two programs:
Tri-County Steer Carcass Futurity (TCS) located at Oakland,
Iowa, and Midcrest Area Cattle Evaluation Program
(MACEP) at Creston, Iowa.  These tests provide producers a
comparison of performance in a feedlot environment,
carcass information, and a demonstration of the economics
of retained ownership.  Consignors' calves are managed and
fed for maximum gain so genetic differences for ADG are
fully expressed and non-feed costs are minimized.
Producers are given a detailed accounting of feed, yardage
and medicine charges for each steer.
For each steer, cumulative ADG is calculated at least
four times during each test and FE is calculated at the end of
each test.  Thus, producers can learn about the pattern of
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their steers' ADG as days on feed increase.  Value-based
marketing is demonstrated by selling the cattle on a carcass
weight and grade basis with packer discounts for less
desirable quality and yield grades and carcass weights.
Breeding and management programs are compared with
those of other producers and with industry benchmarks.
Informed decisions about breeding, feeding, health
programs, management, and marketing can then be made to
improve productivity and profitability.
The objectives of this retrospective study were to:
1. Determine the effect of Bovine Respiratory Disease
on economic and performance parameters in a standardized
steer test.
2. Determine factors that most accurately predict the
incidence of Bovine Respiratory Disease in a standardized
steer test.
Materials and Methods
A retrospective study of health, performance, and
carcass records on 2,544 calves in twenty feedlot tests was
conducted.  TCS calves entering the tests originated in
southwest Iowa, primarily from Cass, Shelby,
Pottawattamie, Page, Mills, and Montgomery counties.
MACEP steers could originate from any county but those
from Adair, Adams, Clarke, Decatur, Madison, Ringgold,
Taylor, and Union counties were given preference if space
was limited.  The number of calves per consignor ranged
from one to 43 for all tests.  The average number of calves
per consignor per test was 4.2.  Producers were encouraged
to enter calves that were representative of their herd's
genetics so that performance and carcass data were useful
for later decision-making.  However, it is likely that some
producers were also interested in being recognized for
having steers that rank high for retail value produced per
day on feed.  Therefore, some producers were likely to
consign what they believed to be their highest quality,
fastest gaining steers.
From 1988 to 1997, eight MACEP tests at three
different feedyards were analyzed.  The MACEP tests
began in early September each year. Twelve TCS tests at
three different feedyards, conducted from 1990 to 1997,
began in either October or November each year. The "year"
is when the test ended.   A major difference between the
tests was that only 2% of MACEP steers were weaned 10
days or more prior to delivery to the test feedlot, whereas
92% of the TCS steers were weaned.  The average age and
weight at the beginning of the tests were 195 days and 572
pounds, respectively.  Upon arrival at the test feedlot, calves
were vaccinated for IBR, PI3, BVD, BRSV (vaccines for
these four were MLV), Haemophilus somnus, and
Pasteurella haemolytica, were treated for internal and
external parasites, were given a unique identification tag,
and were implanted and weighed.  Calves were weighed
three more times during each test at approximately 28, 100
and 200 days and were harvested at one of two times
approximately 35 days apart.  Harvest times averaged
180-220 and 210-240 days on feed.  Participants selected the
harvest dates they considered most beneficial for each steer.
In the TCS tests, producers were encouraged to not sell
cattle that had < .35 inches of backfat.   A disposition score
was assigned to 1178 calves in nine tests at each weigh
period.  Disposition scores were based on a subjective
appraisal of disposition while being processed.  Disposition
scores ranged from 1 to 5: docile=1, fractious=5.  Birth
dates were provided for 83% of the calves.
Rations averaged 62 Mcal Neg/pound after 14 days.
Rations and gain were periodically monitored with the Iowa
State University Extension Feedlot MonitoringR program.
Feed intake for maintenance was assigned to each calf by
weight using National Research Council requirements.
After feed for maintenance was calculated for the entire pen,
the remaining feed was allocated for gain, with the
assumption that feed for gain was used equally efficiently by
all animals. Carcass weight, quality grade, and yield grade
were used to calculate carcass value.  Select quality grade
carcasses were discounted relative to the choice-prime base.
Yield-grade 4 and 5 carcasses were discounted relative to
yield grade 1, 2, and 3 carcasses.  For this study, live selling
price per pound was reverse calculated from the carcass
weight, yield, and revenue.  To determine net profit for this
analysis, the beginning value, feed costs, yardage costs
($.25/head/day), miscellaneous costs, transportation costs,
carcass data collection costs, vaccination, veterinary
treatment costs (other than for BRD), implanting and
identification tag costs, interest opportunity cost (6%
amortized over the number of days on feed) on the initial
feeder calf value, and costs to treat BRD were subtracted
from the total carcass value (carcass price per pound
multiplied by carcass weight).
All costs were recorded and added to the beginning
value of the cattle that died (n=23, 1.1% of all steers) to
determine net profit (loss).  Nine (0.4%) calves with chronic
disease conditions were removed from the test at the
discretion of the owner.  One-half of the beginning value per
pound of culled steers was multiplied by the weight at
removal and designated as the "sale" value.  All costs plus
beginning value was subtracted from this standardized sale
value to determine net profit (loss).  The figure of one-half
of the beginning value per pound was an estimate of what
the selling price would have been if culls had been marketed
as single lots at an auction market.
At least two weeks prior to entering the tests, steers
were vaccinated for IBR, PI3, BVD, BRSV, Haemophilus
somnus, Pasteurella haemolytica, and 7-way Clostridia, and
were dewormed, and treated for lice and grubs. (Not all
calves were vaccinated for Pasteurella haemolytica)
Castration and dehorning were required if necessary. Health
procedure requirements were based on rules of the Iowa
Beef Cattle Pre-Conditioning program.  Only 1995, 1996,
and 1997 tests were used to analyze vaccine effects because
specific vaccine product information was not recorded prior
to that time.  For these 3 years, 73% of the calves had papers
signed by a veterinarian stating the vaccine product used and
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the date it was administered.  For some producers, the
veterinarian did not administer the vaccinations but advised
which product should be used, sold the product, and issued
a certificate stating the date and specific product used by the
owner.   Although owner vaccination does not meet the
requirements of the Iowa preconditioning program, these
calves were included in the analysis of factors that affect
feedlot respiratory disease.
Calves were treated for a variety of conditions,
including respiratory disease, bloat, acidosis, footrot, and
central nervous system disorders.  Consulting veterinarians
and feedyard managers did not use a predefined standard for
identifying cattle with respiratory disease for all tests.
Diagnosis of respiratory disease was based on observation
of clinical signs including inappetence, labored breathing,
depression, and elevated body temperature.  Some calves
were treated based upon the visual signs of respiratory
disease without measuring body temperature.   Steers were
observed for signs of disease twice each day.  Treated steers
were generally not isolated in a sick pen.
Cattle diagnosed with respiratory disease were treated
with pharmaceutical products recommended by the
consulting veterinarian.  For each treatment, the animal ID,
medication and dosage used, cost, date, and diagnosis were
recorded.  If a veterinarian provided treatment, the call
charge for that feedlot visit was amortized over all cattle
treated that day.  For this analysis a chute charge of
$1.00/head was charged if the feedlot manager performed
the individual treatments.  The consulting veterinarian
performed approximately 17% of individual treatments for
all conditions.  The feedlot manager treated the remainder.
Treatments performed within two days on the same calf
were considered to be one treatment, inasmuch as treatment
protocols often required routine re-treatment.  This is in
accordance with label recommendations of several
commonly used antibiotics.  Morbidity of respiratory
disease was defined as the number of treatments.  Costs to
treat diseases and disorders other than BRD were reported
in the miscellaneous cost category for each animal and
therefore affected net profit.
Calf value at the beginning of the each test was based
on USDA Oklahoma City reported prices.  For the week
and year that each test began, USDA price quotes for calves
in each 50-pound weight range were matched to each calf.
Four hundred ninety-six (496) steers and heifers in nine
tests at five different feedlots had  known birth and weaning
dates, beginning weights, and vaccine products used.  This
included two tests in which only heifers were fed.  These
two heifer tests were used only to determine predisposing
factors to respiratory disease.  These cattle were vaccinated
at least two weeks prior to each test.  These 496 calves were
used to analyze the effects of age, weaning status, and
vaccine type on BRD.  The multiple logistic regression
procedure of SAS was used; BRD was the dependent
variable and was defined as the occurrence or
non-occurrence of BRD.  Year, test center, weaning status
(weaned or non-weaned), age when the test began,
beginning weight and vaccine type (MLV or killed) were
initially included in the model as independent variables.
Three test centers, age, weaning status, and vaccine type
were the only independent variables that resulted in a
maximum likelihood estimate chi-square value of p<.05 and
these were the variables used in the final model.
To elucidate components of the net profit difference
between steers treated or non-treated for BRD, five
categories were used.  These were all costs associated with
treated steers that died, BRD treatment costs of steers that
survived to harvest, performance, carcass quality grade, and
marketing time differences between treated and non-treated
steers.  Costs associated with treated steers that died or left
the test due to chronic disease included their value loss, their
feed and yardage charges, and their BRD treatment costs.
Performance costs were feed, yardage and non-BRD
veterinary charges of the steers that survived to harvest.
Differences in net profit due to improved carcass quality
grade of the non-treated steers were calculated such that
they were independent of the improved marketing time of
non-treated steers.  Differences in net profit due to improved
marketing time of the non-treated steers were calculated
such that they were independent of improved carcass quality
grade of the non-treated steers.
 One thousand seven hundred eighty-two steers from 17
tests and six different feedlots were used to determine if
weight per day of age at the beginning of the test differed
between steers treated or non-treated for BRD.  The GLM
procedure of SAS was used; year and test center were
included in the model statement.
Complete records on gain, yardage, feed, veterinary
costs, and slaughter information were available on 2,114 of
2,146 steers in 17 tests at six different feedlots.  Twenty-
three steers died and nine left the test due to chronic disease.
For the 2,114 steers that finished the test, the GLM
procedure of SAS was used to analyze the effects of BRD
status (those not treated, treated once, treated twice, and
treated >=3 times) on beginning ADG (gain during the first
28 days of the test), test ADG (gain from 28 days after
arrival to harvest), days on feed to harvest, final weight at
harvest, and selling price.  For all 2146 steers, the GLM
procedure of SAS was used to analyze the effects of BRD
status on net profit.  Bovine respiratory disease was not used
as a continuous variable because of the low number of
animals treated >= 3 times. For all analyses, year and test
center were included in the model statement.  For selling
price and days on feed, year, test center, and age when the
test began were included in the model statement.
Differences between BRD status group least squares means
were considered significant if p<.05 for the pairwise
comparison of least squares means.
The GLM procedure of SAS was used to determine the
effect of disposition scores (1, 2, 3, or >=4) on ADG and net
profit for 1178 steers in 9 tests.  Disposition scores were not
used as continuous variables because of the low number of
steers that were disposition scored 4 or 5.  Differences
between disposition score groups were considered
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significant if p< .05 for the pairwise comparison of least
squares means.
Results and Discussion
Unadjusted data for all the tests appear in Table 1.
Respiratory (BRD) morbidity was 20.6%.  Although this
seems high relative to other trials (Bechtol et al., 1991),
cattle originated from many sources, and 38% were less
than 200 days of age when delivered.  BRD morbidity for
the various tests ranged from 0 to 59%.   These large
differences clearly demonstrate the importance of numerous
replicates when examining the effect of variables on BRD.
The large variation in morbidity may be due to differences
in weather, ration, stress on individual animals, level of
exposure to pathogens, and possibly to virulence of those
pathogens. Relapse rate ranged from 0 to 81 percent.  Much
of the variability in net profit was due to variation in cattle
market and feed prices among years and tests.
Table 1.  Overall performance, BRD morbidity, costs, and profitability of steers in the TCS and MACEP steer tests.
Test
and
year a
BRD
Morbidityb,c
(%)
Case
Fatalityd
(%)
First
Treatment
Relapse
Rate (%)e
BRD
Treatment Costs
($/ All Head) f
A
D
Gg
Total
Cost
of Gain
($/Cwt)
Selling
Price
($/Cwt)
Net
Profit
($/
Head)
MACEP 88 7 20 0 2.10 3.0 43.2 61.8 32
MACEP 89 9 0 25 3.30 3.4 49.9 71.3 47
MACEP1-90 40 10 40 9.60 3.2 44.4 76.9 123
TCS 90 18 5 32 2.50 3.3 40.6 75.7 93
MACEP 1-91 53 15 22 18.60 2.8 53.1 75.5 -7
TCS 91 26 0 12 1.70 3.1 46.6 69.9 -60
TCS 92 16 0 0 1.20 3.4 47.5 70.5 45
TCS 93 0 0.00 2.9 46.2 74.2 46
MACEP 94 30 7 24 5.80 3.3 43.6 67.7 -2
TCS 94 20 0 17 2.50 3.4 48.0 59.4 -134
MACEP 95 7 17 25 2.20 3.3 37.3 63.0 81
TCS 95 21 6 44 3.90 3.2 47.4 60.3 47
MACEP 96 37 8 32 8.6 3.2 53.0 56.7 -40
TCS 1-96 59 5 68 17.2 3.1 57.0 57.5 -70
TCS 2-96 4 22 11 1.00 3.2 66.2 56.7 -121
MACEP 97 5 0 0 0.60 3.1 50.7 65.2 104
TCS 1-97 26 0 81 4.30 3.1 46.5 65.3 95
Weighted
Averages
20.6 6.0 39.2 4.30 3.2 49.0 64.7 18
a
 Year is the year the test was completed.
b
 BRD (Bovine Respiratory Disease) morbidity: percentage of cattle treated for respiratory disease.
c
 BRD morbidity, case fatality, BRD treatment costs and net profit reflect the average of all steers, including those that died.
d
 Of the cattle treated for BRD, the percentage that died or left the test due to chronic disease.
e Percentage of calves treated that required treatment again.
f Costs to treat BRD amortized over all steers in the test.
g
 ADG (average daily gain), total cost of gain, and selling price reflect only steers that finished the test.
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The average cost of BRD treatments for all steers that
were treated was $21.06/hd.  The average number of
treatments for each animal treated was 1.7.  Therefore, the
cost to treat each BRD case was $12.39 ($21.06/1.7).  Of
this amount, 81% was for drug costs and 19% was for
veterinary and feedlot services.  Treatment for BRD was
87% of the cost of treatment for all diseases.  Figure 1
depicts the trend and variation for BRD treatment cost and
the number of treatments per animal that required BRD
therapy.  More treatments per animal meant higher relapse
rates.  Neither the cost per treatment nor the number of
treatments per animal treatment showed an explainable
trend. Table 2 depicts various costs, and performance and
economic parameters for calves sold at harvest (n = 2114)
by BRD status (not treated for respiratory disease, treated
once, twice, or 3 or more times).  Data from steers that died
or left the test were not included.  Although ADG was
reduced for treated steers for the first 28 days after arrival
at the test center, treated and non-treated steers did not
differ for the test period, which was from 28 days after
arrival to harvest.  One study demonstrated that 68% of
steers that did not have overt clinical signs of BRD had
lung lesions at harvest.  These steers gained .17 pounds per
day less than steers that did not have lung lesions (Wittum
et al., 1996).
Table 2.  Least squares means for performance parameters of 2,114 steers in the TCS and MACEP steer tests, 1988-
1997.  These data do not include steers that died.
BRD status
(Number
of treatments)
Number of
steers
28 day
ADGa
Test
ADGb
DOFc % >=
Choice-
QGd
Sell
Price
($/Cwt)
Final
Wgt
(#)
BRD
treatment
costs ($/Head)
Not Treated 1699 2.72e 3.22e 207e 54 % 68.58e 1226e 0e
1 261 2.19f 3.24e 209e 49 % 67.97f 1227e 13f
2 98 1.94f,g 3.30e 209e,f 51 % 68.14e,f 1230e 24g
>=3 56 1.66g 3.16e 216f 45 % 66.20g 1193f 40h
All Treated 415 2.06i 3.24 212i 49% 67.90i 1223 18.1i
a
 ADG from arrival at the test center to 28 days.
b
 ADG from 28 days after arrival to harvest.
c
 Number of days on feed from arrival at the test center to harvest.
d
 Percentage of steer carcasses that were at least Quality Grade Choice minus.
 e-h
 Least-squares means within a column without a common superscript differ (p<.05).
i Least squares means differ between treated and non-treated steers (p<.05).
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Figure 1.  Cost for each BRD treatment and number of treatments per head treated by year in TCS and MACEP
tests, 1988 to 1997.
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The difference in early ADG (Table 2) is explained by
Figure 2, which shows that in tests with either high (>20
%) or low (<20%) BRD morbidity, most of the treatments
occurred early in the feeding period.  Specifically, 40% of
first treatments occurred within 14 days of arrival for
either high or low BRD-morbidity tests (Figure 3).  In
high morbidity tests, 81% of first treatments occurred
during the first 42 days (Figure 3).  It seems that
compensatory gain throughout the test period made up for
the BRD-induced reduction in ADG during the first 28
days. These data show that cattle that are treated effectively
do not experience a reduction in ADG.
Figure 2.  Percentage distribution of the number of days to the first BRD treatment for calves in TCS and
MACEP tests, 1988 to 1997, with high (>=20%) or low (<20%) levels of BRD morbidity.
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Figure 3.  Percentage distribution of the number of weeks to the first BRD treatment for calves in TCS and
MACEP tests, 1988 to 1997, with high (>=20%) or low (<20%) levels of BRD morbidity.
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Table 3 depicts all steers, including those that died or left
the test due to chronic disease.  Net profit differences
between BRD treatment group least squares means are
greater than in Table 2 because mortality was higher for
steers that experienced BRD.  This higher mortality
caused lower sale values, as demonstrated by the group
that was treated 3 or more times (>=3x).  Twenty percent
of the >=3x group died or were culled before completing
the test, which reduced the average gross sale value to
$650.  Additionally, BRD treatment costs were $53.70/hd
for the >=3x group, further reducing their net profit.
Tables 2 and 3 demonstrate that BRD does not cause large
performance differences but accounts for increased
mortality, culling, and treatment costs, significantly
affecting net profit.
Figure 4 depicts components of the value differences
between treated and non-treated steers.  Non-treated steers
returned $57.48 more per head than treated steers.  The
largest component of the difference, $28.90, is from value
losses, feed and yardage charges, and medicine charges for
treated steers that died or left the test due to chronic
disease.  Costs to treat BRD for treated steers that survived
to harvest further reduced the treated steers’ net profit by
$18.10.  Improved ADG and FE of the non-treated steers
contributed $2.00 to the net profit difference.  Improved
quality grade, independent of marketing time, contributed
$2.38 to the net profit difference.  Earlier marketing,
independent of quality grade, contributed $6.10 to the net
profit difference.
Table 3.  Least squares means for net profit and mortality of 2,146 steers in the TCS and MACEP tests, 1988 to 1997.
These data include steers that died.
BRD Status
 (Number of  treatments)
Number of
steers
Net Profit
($/Head)
Case
Fatality a %
Sell Value b
($/Head)
BRD Treatment
Costs ($/Head)
Not Treated 1705 61c .35 % 840c 0c
1 270 31d 3.3 % 820d 12.7d
2 102 10e 3.9 % 813d 24.9e
>=3 69 -108f 20.3 % 650e 53.7f
All Treated 441 3g 5.9 % 793g 20.6g
a
 Of the steers in the BRD group (row), the percentage that died or left the test due to chronic disease.
b
 The value of the steers leaving the test, including those sold at harvest, those that died, and those that left the test due to
chronic disease.
c-f
 Least squares means within a column without a common superscript differ (p<.05).
g
 Least squares means differ between treated and non-treated steers (p<.05).
Figure 4.  Components of the net profit difference between steers treated or non-treated for BRD, respectively,
in TCS and MACEP tests, 1988 to 1997.
NUMBER OF HEAD = 2146 MORBIDITY = 20.6%
MORTALITY = 1.2%CASE FATALITY = 5.9 %
DEAD
CHARGES=
$28.90 QUALITY
GRADE =$2.38
BRD  TREATMENT=
$18.10
MARKETING
TIME =$6.10
NET PROFIT DIFFERENCE =  $57.48 / HEAD
PERFORMANCE =
$2.00
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Although disposition score did not account for
differences in morbidity, ADG and net profit were
statistically lower (Figure 5) for wilder steers (disposition
scores 2, 3, and >=4) than for docile steers (disposition
score 1) on a 5 point disposition scale. The least squares
means for net profit for all disposition scores are negative
because the nine tests that measured disposition score
occurred in low profit years.
Younger calves had higher BRD morbidity than older
calves (Figure 6).    Although age seems to explain the
occurrence of BRD, older calves were also more likely to
have been weaned prior to consignment to the tests.
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Figure 6.  The effect of age at the beginning of test on BRD morbidity in TCS and MACEP tests, 1988 to 1997.
Figure 5.  The effect of disposition score on average daily gain and net profit for steers in TCS and MACEP tests,
1988 to 1997.  All values are least squares means.
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Both non-weaned calves and calves weaned less than
30 days had higher BRD rates than calves weaned more
than 30 days (Figure 7).  Again, calves weaned more than
30 days were older than those that were not weaned or
weaned fewer than 30 days.  The percentage of treated
calves that relapsed, or required treatment again was
numerically highest for those weaned less than 30 days.
Calves vaccinated at least 10 days before the test with
killed IBR, BVD, BRSV, and PI-3 vaccines had higher
BRD rates than those vaccinated with modified live (MLV)
products (Figure 8).  Fifty-two percent of treated calves
relapsed in each group. The most important difference
between the two vaccine groups is the higher percentage of
killed vaccine calves that required treatment 3 or more
times.  Calves treated 3 or more times earned $174 less net
profit than those that were not treated (Table 3).
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Figure 8.  The effect of pre-trial vaccine type (MLV or killed) on BRD morbidity in TCS and MACEP tests, 1995
to 1997.
Figure 7.  The effect of weaning status on BRD morbidity in TCS and MACEP tests, 1988 to 1997.
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Although treated steers were younger at the start of
the test than non-treated steers, they were not lighter.
Weight per day of age at the beginning of the test was
higher (p< .05) for treated than non-treated steers for all
years combined (Figure 9).
The results of the logistic regression analysis of
factors that predict BRD are presented in Table 4.  The
purpose of this analysis was to determine the significance
of age, weaning status (weaned or non-weaned), and
vaccine group (MLV or killed) on BRD.  Age, weaning
status, and vaccine group (killed or MLV) were the
independent variables and BRD status (whether treatment
occurred or not) was the dependent variable.  Age was an
important predictor of BRD (p< .01), but an odds ratio
could not be determined because age is not a discrete event
like weaning or vaccine status.  The result of each factor is
presented as an odds ratio, and each result is statistically
adjusted for the other factors.  Non-weaned calves were 3.4
times more likely to experience BRD than weaned calves,
independent of differences in age, test center, or vaccine
status.  Calves vaccinated with killed vaccines were 2.2
times more likely to experience BRD than calves
vaccinated with MLV vaccines, independent of other
factors.
.
Table 4.  Risk of BRD for non-weaned vs. weaned calves and calves vaccinated with killed vs. MLV vaccines in the
TCS and MACEP tests, 1995 to 1997.
Odds ratioa
Weaning status
Weaned 1.0
Non-Weaned 3.4b
Vaccine Type
MLV 1.0
Killed 2.2c
a
 The final model adjusts all odds ratios for the effect of age, center, weaning status, and vaccine type.
b
 Odds that non-weaned calves will experience BRD compared with weaned calves (p<.01).
c
 Odds that calves vaccinated with killed vaccines will experience BRD compared with calves vaccinated with MLV vaccines
(p<.01).
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Figure 9.  Least squares means by year for weight per day of age at test entry for TCS and MACEP tests.
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Implications
Steers that were diagnosed and treated for BRD
were less profitable than steers not diagnosed with
BRD, primarily from higher mortality and
medicine costs.  Treated steers’ ADG was similar
to non-treated steers.   However, lung infections
can occur without clinical signs in some animals,
and this may cause a reduction in their ADG.
Lung infections without overt clinical signs can
only be determined by the presence of lung lesions
at harvest, which was not performed in this study.
Some management and vaccination systems will
reduce the occurrence of BRD, and should
increase net profit.  Culling wild steers will not
reduce the occurrence of BRD, but will increase
ADG and net profit.
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